{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:44:41Z","timestamp":1790912681173,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2016-05820"],"award-info":[{"award-number":["RGPIN-2016-05820"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Quebec Health Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004889","name":"Fondation CHU de Qu\u00e9bec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004889","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008240","name":"Fonds de Recherche du Qu\u00e9bec-Soci\u00e9t\u00e9 et Culture","doi-asserted-by":"publisher","award":["2021-AUDC-288468"],"award-info":[{"award-number":["2021-AUDC-288468"]}],"id":[{"id":"10.13039\/100008240","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jconrel.2022.12.005","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T12:24:56Z","timestamp":1670934296000},"page":"611-620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["The mechanisms of anti-PEG immune response are different in the spleen and the lymph nodes"],"prefix":"10.1016","volume":"353","author":[{"given":"Philippe","family":"Grenier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Ch\u00e9nard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jconrel.2022.12.005_bb0005","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles-from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.12.005_bb0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.jconrel.2022.12.005_bb0015","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"issue":"2","key":"10.1016\/j.jconrel.2022.12.005_bb0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0005-2736(91)90201-I","article-title":"Pharmacokinetics of stealth versus conventional liposomes - effect of dose","volume":"1068","author":"Allen","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2022.12.005_bb0025","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1126\/science.8128245","article-title":"Biodegradable long-circulating polymeric nanospheres","volume":"263","author":"Gref","year":"1994","journal-title":"Science (Washington, D. C., 1883)"},{"issue":"4","key":"10.1016\/j.jconrel.2022.12.005_bb0030","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1021\/ja2084338","article-title":"Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake","volume":"134","author":"Walkey","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2022.12.005_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0005-2736(91)90246-5","article-title":"Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo","volume":"1066","author":"Allen","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.jconrel.2022.12.005_bb0040","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0024-3205(97)00539-0","article-title":"Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles","volume":"61","author":"Peracchia","year":"1997","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2022.12.005_bb0045","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1039\/c0py90001j","article-title":"Polymer-protein conjugates: an enzymatic activity perspective","volume":"1","author":"Gauthier","year":"2010","journal-title":"Polym. Chem."},{"issue":"10","key":"10.1016\/j.jconrel.2022.12.005_bb0050","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/S0021-9258(17)40292-4","article-title":"Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase","volume":"252","author":"Abuchowski","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2022.12.005_bb0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/10717540600814402","article-title":"Pharmacokinetic consequences of pegylation","volume":"13","author":"Hamidi","year":"2006","journal-title":"Drug Deli."},{"key":"10.1016\/j.jconrel.2022.12.005_bb0060","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of Pegylation of pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.jconrel.2022.12.005_bb0065","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1517\/17425247.2012.720969","article-title":"Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents","volume":"9","author":"Garay","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.12.005_bb0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0168-3659(02)00462-5","article-title":"Accelerated blood clearance of PEGylated liposomes in rats after repeated injections","volume":"88","author":"Ishida","year":"2003","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2022.12.005_bb0075","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-3565(24)35391-1","article-title":"Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes","volume":"292","author":"Dams","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2022.12.005_bb0080","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijpharm.2010.03.022","article-title":"T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes","volume":"392","author":"Koide","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.12.005_bb0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jconrel.2006.08.001","article-title":"Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes","volume":"115","author":"Ishida","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.12.005_bb0090","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jconrel.2007.05.015","article-title":"PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner","volume":"122","author":"Ishida","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.12.005_bb0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jconrel.2018.08.022","article-title":"Anti-polyethylene glycol antibodies alter the protein corona deposited on nanoparticles and the physiological pathways regulating their fate in vivo","volume":"287","author":"Grenier","year":"2018","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.jconrel.2022.12.005_bb0100","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s11095-016-1961-x","article-title":"The mystery of antibodies against polyethylene glycol (PEG) - what do we know?","volume":"33","author":"Lubich","year":"2016","journal-title":"Pharm. Res."},{"issue":"21","key":"10.1016\/j.jconrel.2022.12.005_bb0105","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1021\/acs.analchem.6b03109","article-title":"Measurement of pre-existing IgG and IgM antibodies against polyethylene glycol in healthy individuals","volume":"88","author":"Chen","year":"2016","journal-title":"Anal. Chem."},{"issue":"23","key":"10.1016\/j.jconrel.2022.12.005_bb0110","doi-asserted-by":"crossref","first-page":"11804","DOI":"10.1021\/acs.analchem.6b03437","article-title":"Analysis of pre-existing IgG and IgM antibodies against polyethylene glycol (PEG) in the general population","volume":"88","author":"Yang","year":"2016","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2022.12.005_bb0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cncr.22739","article-title":"Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients","volume":"110","author":"Armstrong","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2022.12.005_bb0120","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar1861","article-title":"Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase","volume":"8","author":"Ganson","year":"2005","journal-title":"Arthritis Res. Therapy"},{"issue":"5","key":"10.1016\/j.jconrel.2022.12.005_bb0125","first-page":"655","article-title":"Anti-PEG immunity: emergence, characteristics, and unaddressed questions","volume":"7","author":"Yang","year":"2015","journal-title":"Wiley Interdiscipl. Rev.: Nanomed. Nanobiotechnol."},{"issue":"8","key":"10.1016\/j.jconrel.2022.12.005_bb0130","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.12.005_bb0135","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nnano.2012.207","article-title":"Biomolecular coronas provide the biological identity of nanosized materials","volume":"7","author":"Monopoli","year":"2012","journal-title":"Nat. Nanotechnol."},{"issue":"2","key":"10.1016\/j.jconrel.2022.12.005_bb0140","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2011.09.098","article-title":"The journey of a drug carrier in the body: an anatomo-physiological perspective","volume":"161","author":"Bertrand","year":"2012","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2022.12.005_bb0145","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.apsb.2021.02.022","article-title":"Innate and adaptive immune responses towardY nanomedicines","volume":"11","author":"Viana","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"9","key":"10.1016\/j.jconrel.2022.12.005_bb0150","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.jconrel.2022.12.005_bb0155","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ni.3858","article-title":"Novel mechanisms and functions of complement","volume":"18","author":"Hajishengallis","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2022.12.005_bb0160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2020.04.012","article-title":"Complement activation by drug carriers and particulate pharmaceuticals: principles, challenges and opportunities","volume":"157","author":"Moghimi","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2022.12.005_bb0165","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.apsb.2021.02.022","article-title":"Innate and adaptive immune responses toward nanomedicines","volume":"11","author":"Viana","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.jconrel.2022.12.005_bb0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/08982100801893986","article-title":"Physicochemical characterization and study of in vitro interactions of pH-sensitive liposomes with the complement system","volume":"18","author":"Carmo","year":"2008","journal-title":"J. Liposome Res."},{"issue":"36","key":"10.1016\/j.jconrel.2022.12.005_bb0175","doi-asserted-by":"crossref","first-page":"18875","DOI":"10.1039\/D0NR04100A","article-title":"Role of the complement cascade in the biological fate of liposomes in rodents","volume":"12","author":"Viana","year":"2020","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.jconrel.2022.12.005_bb0180","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41467-017-00600-w","article-title":"Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics","volume":"8","author":"Bertrand","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.12.005_bb0185","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jconrel.2021.11.042","article-title":"Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement","volume":"341","author":"Senti","year":"2022","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.jconrel.2022.12.005_bb0190","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nri1669","article-title":"Structure and function of the spleen","volume":"5","author":"Mebius","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.12.005_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102627","article-title":"Marginal zone B cells: from housekeeping function to autoimmunity?","volume":"119","author":"Palm","year":"2021","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.jconrel.2022.12.005_bb0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nri2454","article-title":"The who, how and where of antigen presentation to B cells","volume":"9","author":"Batista","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.jconrel.2022.12.005_bb0205","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nri799","article-title":"Marginal-zone B cells","volume":"2","author":"Martin","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2022.12.005_bb0210","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jconrel.2007.05.015","article-title":"PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner","volume":"122","author":"Ishida","year":"2007","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.jconrel.2022.12.005_bb0215","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/01926230600867727","article-title":"Normal structure, function, and histology of lymph nodes","volume":"34","author":"Willard-Mack","year":"2006","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"10.1016\/j.jconrel.2022.12.005_bb0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(01)00150-8","article-title":"The physiology of the lymphatic system","volume":"50","author":"Swartz","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.jconrel.2022.12.005_bb0225","doi-asserted-by":"crossref","first-page":"7226","DOI":"10.1021\/acs.nanolett.9b02834","article-title":"Nanoparticle size influences antigen retention and presentation in lymph node follicles for humoral immunity","volume":"19","author":"Zhang","year":"2019","journal-title":"Nano Lett."},{"issue":"9","key":"10.1016\/j.jconrel.2022.12.005_bb0230","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1248\/bpb.b20-00345","article-title":"Pegfilgrastim (PEG-G-CSF) induces anti-polyethylene glycol (PEG) IgM via a T cell-dependent mechanism","volume":"43","author":"Elsadek","year":"2020","journal-title":"Biol. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.jconrel.2022.12.005_bb0235","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2022.12.005_bb0240","doi-asserted-by":"crossref","first-page":"7765","DOI":"10.1038\/ncomms8765","article-title":"Nanoparticles with photoinduced precipitation for the extraction of pollutants from water and soil","volume":"6","author":"Brandl","year":"2015","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.jconrel.2022.12.005_bb0245","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1021\/nl302638g","article-title":"PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics","volume":"12","author":"Perry","year":"2012","journal-title":"Nano Lett."},{"issue":"11","key":"10.1016\/j.jconrel.2022.12.005_bb0250","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1021\/acs.nanolett.0c05056","article-title":"Isolating nanoparticles from complex biological media by immunoprecipitation","volume":"21","author":"Hacene","year":"2021","journal-title":"Nano Lett."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2022.12.005_bb0255","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jim.2007.08.004","article-title":"Hock immunization: a humane alternative to mouse footpad injections","volume":"328","author":"Kamala","year":"2007","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.jconrel.2022.12.005_bb0265","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0005-2736(93)90115-G","article-title":"Subcutaneous administration of liposomes - a comparison with the intravenous and intraperitoneal routes of injection","volume":"1150","author":"Allen","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"issue":"2\u20133","key":"10.1016\/j.jconrel.2022.12.005_bb0270","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/08982109709035499","article-title":"Subcutaneous administration of liposomes for lymphatic targeting","volume":"7","author":"Oussoren","year":"1997","journal-title":"J. Liposome Res."},{"issue":"1","key":"10.1016\/j.jconrel.2022.12.005_bb0275","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.biomaterials.2005.05.082","article-title":"The effect of methoxy-PEG chain length and molecular architecture on lymph node targeting of immuno-PEG liposomes","volume":"27","author":"Moghimi","year":"2006","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2022.12.005_bb0280","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0014-5793(94)00351-3","article-title":"Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes","volume":"344","author":"Moghimi","year":"1994","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.jconrel.2022.12.005_bb0285","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0014-5793(96)01408-1","article-title":"Lymph node localisation of biodegradable nanospheres surface modified with poloxamer and poloxamine block co-polymers","volume":"400","author":"Hawley","year":"1997","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.jconrel.2022.12.005_bb0290","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s11095-012-0934-y","article-title":"Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug","volume":"30","author":"Saadati","year":"2013","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2022.12.005_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics3010001","article-title":"Anti-PEG IgM response against PEGylated liposomes in mice and rats","volume":"3","author":"Ichihara","year":"2010","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.jconrel.2022.12.005_bb0300","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1248\/bpb.b12-00276","article-title":"Intravenous Administration of Polyethylene Glycol-Coated (PEGylated) proteins and PEGylated adenovirus elicits an anti-PEG immunoglobulin M response","volume":"35","author":"Shimizu","year":"2012","journal-title":"Biol. Pharm. Bull."},{"issue":"8","key":"10.1016\/j.jconrel.2022.12.005_bb0305","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1021\/acs.molpharmaceut.0c00366","article-title":"Impact of pre-existing or induced anti-PEG IgM on the pharmacokinetics of Peginterferon alfa-2a (Pegasys) in mice","volume":"17","author":"Elsadek","year":"2020","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2022.12.005_bb0310","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tube.2014.10.012","article-title":"BALB\/c mice display more enhanced BCG vaccine induced Th1 and Th17 response than C57BL\/6 mice but have equivalent protection","volume":"95","author":"Garcia-Pelayo","year":"2015","journal-title":"Tuberculosis"},{"issue":"6","key":"10.1016\/j.jconrel.2022.12.005_bb0315","first-page":"947","article-title":"The effects of complement activation by cobra venom factor on the migration of T and B lymphocytes into rat thoracic duct lymph","volume":"32","author":"Spry","year":"1977","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.jconrel.2022.12.005_bb0320","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nri2656","article-title":"The follicular versus marginal zone B lymphocyte cell fate decision","volume":"9","author":"Pillai","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"63","key":"10.1016\/j.jconrel.2022.12.005_bb0325","article-title":"Marginal zone B-cells, a gatekeeper of innate immunity","volume":"2","author":"Zouali","year":"2011","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.jconrel.2022.12.005_bb0330","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S1074-7613(01)00135-2","article-title":"The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21","volume":"14","author":"Cariappa","year":"2001","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.jconrel.2022.12.005_bb0335","doi-asserted-by":"crossref","first-page":"7198","DOI":"10.4049\/jimmunol.162.12.7198","article-title":"IgM(high)CD21(high) lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells","volume":"162","author":"Oliver","year":"1999","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.jconrel.2022.12.005_bb0340","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood-2006-05-021089","article-title":"Naive recirculating B cells mature simultaneously in the spleen and bone marrow","volume":"109","author":"Cariappa","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2022.12.005_bb0345","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2021.12.033","article-title":"Accelerated blood clearance and hypersensitivity by PEGylated liposomes containing TLR agonists","volume":"342","author":"Stavnsbjerg","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.12.005_bb0350","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jconrel.2009.04.006","article-title":"Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production","volume":"137","author":"Tagami","year":"2009","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.jconrel.2022.12.005_bb0355","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.jconrel.2022.12.005_bb0360","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.molimm.2005.10.004","article-title":"Complement in BuB\/BnJ mice revisited: serum C3 levels and complement opsonic activity are not elevated","volume":"43","author":"Osmers","year":"2006","journal-title":"Mol. Immunol."},{"issue":"5","key":"10.1016\/j.jconrel.2022.12.005_bb0365","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.biomaterials.2006.09.047","article-title":"Formulation of functionalized PLGA\u2013PEG nanoparticles for in vivo targeted drug delivery","volume":"28","author":"Cheng","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.12.005_bb0370","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jconrel.2022.04.009","article-title":"Size exclusion of radioactive polymers (SERP) informs on the biodegradation of trimethyl chitosan and biodegradable polymer nanoparticles in vitro and in vivo","volume":"346","author":"Dikpati","year":"2022","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.jconrel.2022.12.005_bb0375","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11095-020-02877-x","article-title":"Residual solvents in nanomedicine and lipid-based drug delivery systems: a case study to better understand processes","volume":"37","author":"Dikpati","year":"2020","journal-title":"Pharm. Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922008197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922008197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:15:35Z","timestamp":1778505335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922008197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":74,"alternative-id":["S0168365922008197"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.12.005","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mechanisms of anti-PEG immune response are different in the spleen and the lymph nodes","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}